<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010026122">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACLN : Articles dans des revues avec comité de lecture non répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Boulanger, D.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Schneider, Dominique</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Chippaux, Jean-Philippe</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Sellin, Bertrand</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Capron, A.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Schistosoma bovis : vaccine effects of a recombinant homologous glutathione S-transferase in sheep</title>
        <secondary-title>International Journal for Parasitology</secondary-title>
      </titles>
      <pages>415-418</pages>
      <keywords>
        <keyword>SCHISTOSOMIASE</keyword>
        <keyword>BETAIL</keyword>
        <keyword>VACCINATION</keyword>
        <keyword>ETUDE EXPERIMENTALE</keyword>
        <keyword>ETUDE COMPARATIVE</keyword>
        <keyword>GLUTATHIONE S TRANSFERASE</keyword>
        <keyword>AFRIQUE</keyword>
      </keywords>
      <dates>
        <year>1999</year>
      </dates>
      <call-num>fdi:010026122</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>International Journal for Parasitology</full-title>
      </periodical>
      <isbn>0020-7519</isbn>
      <electronic-resource-num>10.1016/S0020-7519(98)00222-7</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010026122</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/pleins_textes_7/b_fdi_59-60/010026122.pdf</url>
        </pdf-urls>
      </urls>
      <volume>29</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>The economic importance of the trematode #Schistosoma bovis$ in African livestock has justified the development of a specific vaccine. Administered preventively to sheep, rSb28GST - the only molecule cloned from #S. bovis$ which has demonstrated vaccine potentialities in goats and cattle - reduced the mean worm burden in vaccinated animals and improved their health status compared with that of non-vaccinated controls. As in goats, but not in bovines, the fecundity of the settled worm pairs was not modified. Therefore, rSb28GST can be proposed as a universal tool for the prevention of clinical disorders engendered by the main schistosome species affecting domestic ruminants in the African continent. (Résumé d'auteur)</abstract>
      <custom6>052SCHIST03</custom6>
    </record>
  </records>
</xml>
